Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Obexelimab (CD19) - Research Grade Biosimilar

Product Specifications

Background

Obexelimab (XmAb5871) is a first-in-class monoclonal antibody that targets CD19 with its variable domain and uses the XmAb immune inhibitory Fc domain to target FcγRIIb, a receptor that inhibits B cell function. Obexelimab is the first drug candidate to our knowledge that targets FcγRIIb inhibition.

Immunogen

Chimeric / CD19 [Homo sapiens]

Clonality

Recombinant Monoclonal

Conjugation

Unconjugated

Type

Primary Antibodies, Biosimilars

Source

CHO cells

Field of Research

Cancer

Purification

>95%

Concentration

Batch dependent

Buffer

PBS buffer pH7.5

Modification

None

Shipping Conditions

Blue Ice

Storage Conditions

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8 ˚ C for 1-2 weeks. Store at -20 ˚ C for 12 months. Store at -80 ˚ C for long term storage.

Fragment

IgG1-kappa

NCBI Organism

Homo sapiens

Other Product Names

XmAb5871

Frequently Asked Questions

More Discoveries

Explore Other Products

Browse additional items from our catalog

Dusp4 sgRNA CRISPR Lentivector (Rat) (Target 2)
K6896703 1.0 µg DNA

Dusp4 sgRNA CRISPR Lentivector (Rat) (Target 2)

Sign In for Pricing
View Details
PPP1R12A
MBS8536054-01 0.1 mL

PPP1R12A

Sign In for Pricing
View Details
PPP1R12A
MBS8536054-02 0.1 mL (AF405L)

PPP1R12A

Sign In for Pricing
View Details
PPP1R12A
MBS8536054-03 0.1 mL (AF405S)

PPP1R12A

Sign In for Pricing
View Details
PPP1R12A
MBS8536054-04 0.1 mL (AF610)

PPP1R12A

Sign In for Pricing
View Details
PPP1R12A
MBS8536054-05 0.1 mL (AF635)

PPP1R12A

Sign In for Pricing
View Details